For the first time, we demonstrate integration involving the tumor suppressor gene KMT2D, representing the potential inactivation of a tumor suppressor gene also recurrently inactivated in MCPyV-negative MCC. The gene discussed is KMT2D; the disease is Merkel cell skin cancer.